New clues to flavivirus replication

Scientists find first 5' promoter element in dengue genome, perhaps explaining why virus loops before being copied

Written byIshani Ganguli
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
For the first time, researchers have found a promoter element in a flavivirus -- specifically, the dengue virus genome. The 5' location of the promoter, revealed in this month's Genes & Development, may explain why the genome of this mosquito-transmitted pathogen must form a loop before it can be copied, opening up new avenues for researchers to explore in developing antiviral therapeutics."There's this emerging concept in RNA virus replication in which the promoter for RNA synthesis sits on the 5' end of the genome and the genome sort of loops back into the 3' end of the genome to deliver [replication machinery]," said Raul Andino at the University of California, San Francisco. The paper employs a "very diverse set of approaches to very solidly demonstrate this elegant gymnastics" in a new class of viruses, he said.RNA-dependent RNA polymerases (RdRps) encoded in the genomes of certain RNA viruses help catalyze their rapid replication, enabling viruses to make up to 10,000 copies within a few hours. Researchers were in the dark, however, about how RdRps can distinguish viral RNA from the cellular mRNA of the virus's host. For this study, Andrea Gamarnik and her team at the Fundacion Instituto Leloir in Buenos Aires compared RNA synthesis of whole and truncated dengue genomes. In radio-labeled replication assays, the researchers found the 5' untranslated region (UTR) of the genome template was far more critical for replication than the 3' UTR. Using a series of mutations and deletions, they narrowed down a putative promoter element to a large stem loop in the 5' UTR. This is an unusual location, according to Gamarnik, since the RdRp must begin RNA synthesis at the 3' end of the genome, "thousands of nucleotides apart from the [putative] promoter." But last year, her group found that the dengue genome forms a circle when it replicates, similar to polio, rotavirus, and other viruses. In the case of dengue, the virus forms the loop by matching up complementary sequences on its 5' and 3' UTRs. These ends might be coming together to bring the RdRp from its recruitment site to where it can begin doing its job, they reasoned.Atomic force microscopy revealed the interaction between the RdRp and looped RNA in detail. "One picture is very powerful to provide a sense of what is going on at a molecular level," said Andino, not a co-author. When the researchers transfected cells with the virus, they found that those without the intact promoter could not replicate, even if their genomes could form the proper loop -- suggesting the 5' promoter is likely playing a key role in the process. A series of other biochemical and genetic tests reaffirmed these results. In RNA viruses like dengue with plus-stranded genomes, genomic RNA is a template for translation as well as for RNA replication. Based on the researchers' findings, RNA polymerases likely compete with ribosomes to start their work at the 5' end, said John Patton at the National Institute of Allergy and Infectious Diseases, who did not participate in this study. The dengue virus genome may use this competition to control when it is replicated or translated, Patton explained, by allowing polymerases to edge out ribosomes or vice versa; Gamarnik and Andino have observed this pattern in poliovirus.What's more, the loop requirement "ensures that the only [genomes] that are replicated are full length," explained Eva Harris at the University of California, Berkeley, also not a co-author. "That's another check mechanism to make sure that what's actually being packaged is capable of going through the complete infectious process.""Because the essential RNA signals found for dengue virus replication are also present in other flavivirus genomes, such as yellow fever, West Nile, and Japanese encephalitis virus, it is likely that our findings can be extrapolated to other members of this family," Gamarnik wrote in an E-mail.Gamarnik added that her team is now trying to understand exactly how the polymerase binds to the promoter and passes from the 5' to 3' end, as well as how it is regulated. Researchers may eventually build on these findings to develop antiviral therapeutics that interfere with RNA synthesis by, for instance, blocking the 5' promoter, Harris added. Ishani Ganguli iganguli@the-scientist.comLinks within this articleC.V. Filomatori, "A 5' RNA element promotes dengue virus RNA Synthesis on a Circular Genome," Genes Dev, 20:2238-49, 2006. http://www.genesdev.org/.T. Toma, "Original sin and dengue fever," The Scientist, June 16, 2003. http://www.the-scientist.com/article/display/21386/Raul Andino http://www.ucsf.edu/bms/faculty/andino.htmlAndrea Gamarnik http://www.hhmi.org/research/scholars/gamarnik_bio.htmlD.E. Alvarez, et al., "Long-range RNA-RNA interactions circularize the dengue virus genome," J. Virol., 79:6631-43, 2005. PM_ID: 15890901John Patton http://www.niaid.nih.gov/dir/labs/lid/patton.htmA.V. Gamarnik and R. Andino, "Switch from translation to RNA replication in a positive-stranded RNA virus," Genes Dev., 12:2293-304, 1998. PM_ID: 9694795Eva Harris http://socrates.berkeley.edu/~idgroup/faculty/harris.html
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform